Transfer of daclatasvir and sofosbuvir's main metabolite, GS-331007, across the human placenta ex vivo

Am J Obstet Gynecol. 2020 Dec;223(6):941-943. doi: 10.1016/j.ajog.2020.08.107. Epub 2020 Aug 30.
No abstract available

Publication types

  • Letter

MeSH terms

  • Antiviral Agents / metabolism
  • Antiviral Agents / pharmacokinetics*
  • Carbamates / metabolism
  • Carbamates / pharmacokinetics*
  • Female
  • Hepatitis C / drug therapy
  • Humans
  • Imidazoles / metabolism
  • Imidazoles / pharmacokinetics*
  • Maternal-Fetal Exchange*
  • Placenta / metabolism*
  • Pregnancy
  • Pregnancy Complications, Infectious / drug therapy
  • Pyrrolidines / metabolism
  • Pyrrolidines / pharmacokinetics*
  • Sofosbuvir / metabolism
  • Sofosbuvir / pharmacokinetics
  • Uridine / analogs & derivatives*
  • Uridine / metabolism
  • Uridine / pharmacokinetics
  • Valine / analogs & derivatives*
  • Valine / metabolism
  • Valine / pharmacokinetics

Substances

  • Antiviral Agents
  • Carbamates
  • GS331007
  • Imidazoles
  • Pyrrolidines
  • Valine
  • daclatasvir
  • Uridine
  • Sofosbuvir